Kaplan Andrew T.
SEC CIK 1752059 · EDGAR
BoughtSold
Most active insiders at KLRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kaplan Andrew T. | Dir, 10% | $134.38M | — |
| 2 | BAIN CAPITAL INVESTORS LLC | 10% | $134.38M | — |
| 3 | Bain Capital Life Sciences Investors, LLC | 10% | $25.00M | — |
| 4 | Koppel Adam | Dir, 10% | $25.00M | — |
| 5 | RTW INVESTMENTS, LP | 10% | $8.00M | — |
| 6 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% | — | — |
| 7 | Renaud Ronald C JR | CEO, Pres, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-04-20 18:00 | 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | Kaplan Andrew T. | Dir, 10% | C - Cnv Deriv | — | +17.86M | 17.86M | New | — |
| DI | 2026-04-20 18:00 | 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | Kaplan Andrew T. | Dir, 10% | P - Purchase | $16.00 | +8.40M | 26.26M | +47% | +$134.38M |
| I | 2023-12-21 | 2023-12-19 | SGRY | Surgery Partners, Inc. | Kaplan Andrew T. | Dir, 10% | J - Other | $0.00 | -474.4K | 49.95M | -0.9% | $0 |
| I | 2023-12-21 | 2023-12-19 | SGRY | Surgery Partners, Inc. | Kaplan Andrew T. | Dir, 10% | S - Sale | $33.44 | -7.83M | 50.42M | -13% | -$261.73M |
Purchase Sale Sale after option exercise All abbreviations